Bayesian network meta-analysis evaluates antidiabetic medications and dementia risk in 4,382,897 patients.
Could diabetes drugs lower dementia risk, or raise it for some patients?
This Bayesian network meta-analysis synthesized data from 28 articles involving 4,382,897 patients to assess antidiabetic drugs and dementia…
Insulin and metformin cut dementia risk, but DPP4 inhibitors may double Alzheimer's risk compared to SGLT2 drugs in diabetes patients.
Mini-review synthesizes dementia risk and cognitive trajectories in individuals with schizophrenia.
Do people with schizophrenia face a higher risk of dementia, and what does that mean for their care?
This mini-review examines the relationship between schizophrenia and dementia, covering Alzheimer's disease, vascular dementia, and other fo…
People with schizophrenia face a two- to threefold higher risk of dementia, but it's not a direct path to Alzheimer's—brain development, agi…
Body weight variability associated with increased dementia risk in meta-analysis of cohort studies
Large weight fluctuations linked to higher dementia risk in research review
A systematic review and meta-analysis of 16 cohort studies found that highest levels of body weight fluctuation were associated with increas…
Large swings in body weight are linked to a higher risk of dementia, including Alzheimer's and vascular types, but not general cognitive dec…